LiquidCell Dx Appoints New Leadership Team
LiquidCell Dx has appointed Mirna Jarosz as Chief Executive Officer and Vincent A. Miller, MD, as Senior Strategic Advisor to enhance its leadership team. This change aims to strengthen the company’s operational and clinical capabilities as it works on advancing its blood-based tumor microenvironment profiling platform.
SAN CARLOS, Calif.–(BUSINESS WIRE)–LiquidCell Dx, a precision diagnostics company building a blood-based platform for tumor microenvironment profiling, today announced the appointment of Mirna Jarosz as Chief Executive Officer and Vincent A. Miller, MD, as Senior Strategic Advisor. The appointments add operating, commercialization and clinical leadership as the company advances its platform and prepares for the next stage of growth. Comprehensive genomic profiling changed oncology by making t